scout
|Videos|May 7, 2020

Targeting CD19 in Diffuse Large B-Cell Lymphoma

Experts in the management of diffuse large B-cell lymphoma (DLBCL) discuss the use of novel CD19-antibody mono- and combination therapies to treat relapsed/refractory subpopulations.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME